| PERIOD ENDING | 31-Dec-08 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,026,000 | 2,898,136 | 1,513,012 | | Cost of Revenue | 1,839,000 | 1,645,435 | 978,065 | | | Gross Profit | 1,187,000 | 1,252,701 | 534,947 | | | Operating Expenses | | Research Development | 592,000 | 269,535 | 133,073 | | Selling General and Administrative | 735,000 | 503,552 | 328,727 | | Non Recurring | 93,000 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (233,000) | 479,614 | 73,147 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46,000 | 51,392 | 36,775 | | Earnings Before Interest And Taxes | (187,000) | 531,006 | 109,922 | | Interest Expense |
-
| 138 | 97 | | Income Before Tax | (187,000) | 530,868 | 109,825 | | Income Tax Expense | (80,000) | 185,985 | 24,038 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (107,000) | 344,883 | 85,787 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (107,000) | 344,883 | 85,787 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($107,000) | $344,883 | $85,787 |
|
1.48% Nasdaq 
0.024 (0.21%) 
Income Statement
